Metastatic Breast Cancer Clinical Trials

Metastatic Breast Cancer: A Persistent Challenge in Cancer Care

Metastatic breast cancer is also known as stage IV breast cancer, presents a formidable challenge in oncology, with a 5-year relative survival rate of approximately 27%. This aggressive form of breast cancer can spread to distant organs, making treatment more complex and challenging.

The survival rates for metastatic breast cancer vary based on factors such as the type of metastases and treatment response. However, it’s essential to note that localized breast cancer, when detected early before it spreads beyond the breast and nearby lymph nodes, has a much higher 5-year relative survival rate, often exceeding 90%.

Hightower is dedicated to advancing treatment options for metastatic breast cancer through new research and personalized approaches.

*Participation in the Clinical Trial is completely free of cost and is your choice.

*To participate, fill out the form, and someone from our research staff will call you to determine your eligibility for the Clinical Research Study.

Cancer Care Advancements through Clinical Trials

Advance Metastatic Breast Cancer occurs when cancer cells spread beyond the breast and nearby lymph nodes to other parts of the body. It is considered an advanced stage of breast cancer and can present significant challenges in treatment and management.

Hightower is researching efficacy of novel drugs for individuals facing metastatic breast cancer. Our team of experts collaborates closely to ensure the best possible outcomes for patients battling this formidable disease.

*All study procedures and study-related treatment, including the investigational drug, are free of cost, and insurance is not required to participate.

*The study doctor will take you through every step of the Clinical Trial before you decide to participate and will answer any questions you have about the study treatment.

What to Expect

If you decide to participate in the Advanced Metastatic Breast Cancer, by filling out the form above, someone from the study team will contact you to determine your eligibility. The team will go over the study details with you to see if you meet the eligibility criteria for Potential Treatment for Breast Cancer.

You will be invited to the study location for screening if you meet the criteria. The study site will be within a 50-mile radius of your current location. The study doctors will advise you on the duration of the clinical trials for cancer and the implications of your involvement in this research study. We invite you to ask as many questions as you like. After thoroughly explaining everything to the participants, they will be requested to sign an Informed Consent Form. We value transparency between our participants and investigators

*Study-related care is offered at no charge. Expert physicians and healthcare professionals conduct thorough physical exams and assessments.*